• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过用单克隆抗体阻断组织因子可预防致死性大肠杆菌败血症性休克。

Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

作者信息

Taylor F B, Chang A, Ruf W, Morrissey J H, Hinshaw L, Catlett R, Blick K, Edgington T S

机构信息

Oklahoma Medical Research Foundation, Oklahoma City.

出版信息

Circ Shock. 1991 Mar;33(3):127-34.

PMID:2044206
Abstract

Gram-negative bacteremia poses a major health problem, causing one-half of cases of lethal septic shock acquired during hospitalization. Bacterial lipopolysaccharide (LPS) and the inflammatory cytokines, tumor necrosis factor (TNF) and interleukin-1 (IL-1), have been shown to be essential mediators of septic shock. Among the effects of these mediators is a coagulopathy that may be triggered by induced expression of tissue factor (TF) on macrophages and endothelial cells. We now report that 500 micrograms/kg of either immunoglobulin G (IgG) or Fab fragments of a monoclonal antibody against TF administered to baboons as a pretreatment attenuates the coagulopathy and protects against LD100 Escherichia coli. This study provides direct evidence of an essential effector role for TF in septic shock.

摘要

革兰氏阴性菌血症是一个重大的健康问题,导致住院期间获得的致死性感染性休克病例中有一半。细菌脂多糖(LPS)以及炎性细胞因子,肿瘤坏死因子(TNF)和白细胞介素-1(IL-1),已被证明是感染性休克的重要介质。这些介质的作用之一是凝血病,它可能由巨噬细胞和内皮细胞上组织因子(TF)的诱导表达引发。我们现在报告,以500微克/千克的免疫球蛋白G(IgG)或抗TF单克隆抗体的Fab片段预处理狒狒,可减轻凝血病并预防LD100大肠杆菌感染。这项研究提供了TF在感染性休克中起重要效应作用的直接证据。

相似文献

1
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.通过用单克隆抗体阻断组织因子可预防致死性大肠杆菌败血症性休克。
Circ Shock. 1991 Mar;33(3):127-34.
2
Study of septic shock in the non-human primate: relationship of pathophysiological response to therapy with anti-TNF antibody.
Circ Shock. 1994 Dec;44(4):221-9.
3
Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
Circ Shock. 1990 Mar;30(3):279-92.
4
Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis.
J Infect Dis. 2003 May 1;187(9):1442-51. doi: 10.1086/374643. Epub 2003 Apr 15.
5
Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli.
Circ Shock. 1991 Feb;33(2):84-91.
6
Prevention or amelioration of morphologic lesions in LD100 E coli-shocked baboons with steroid/antibiotic therapy.
Adv Shock Res. 1983;10:195-215.
7
Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.抗白细胞介素-6单克隆抗体可保护小鼠免受致死性大肠杆菌感染和致死性肿瘤坏死因子-α攻击。
J Immunol. 1990 Dec 15;145(12):4185-91.
8
Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.抗人重组肿瘤坏死因子单克隆抗体在大肠杆菌攻击猪中的疗效。
Am J Pathol. 1992 Nov;141(5):1197-207.
9
The pathophysiology of septic shock: responses to different doses of live Escherichia coli injection in rats.
Adv Shock Res. 1983;9:101-14.
10
Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock.己酮可可碱对致死性大肠杆菌败血症及伴有真菌性感染性休克的播散性念珠菌病期间肿瘤坏死因子产生及存活的影响。
Circ Shock. 1993 Apr;39(4):306-15.

引用本文的文献

1
Postoperative Adhesions: Current Research on Mechanisms, Therapeutics and Preventative Measures.术后粘连:关于机制、治疗方法及预防措施的当前研究
Biomed Mater Devices. 2025 Sep;3(2):897-937. doi: 10.1007/s44174-024-00236-7. Epub 2024 Sep 17.
2
Challenges with measuring tissue factor antigen and activity in human plasma.测量人血浆中组织因子抗原和活性的挑战。
Blood Vessel Thromb Hemost. 2024 Jul 31;1(4):100022. doi: 10.1016/j.bvth.2024.100022. eCollection 2024 Dec.
3
Pathways regulating the levels of tissue factor-positive extracellular vesicles and activation of coagulation in endotoxemic mice.
调节内毒素血症小鼠组织因子阳性细胞外囊泡水平及凝血激活的信号通路。
J Thromb Haemost. 2025 Apr 24. doi: 10.1016/j.jtha.2025.04.012.
4
Inhibiting NINJ1-dependent plasma membrane rupture protects against inflammasome-induced blood coagulation and inflammation.抑制NINJ1依赖性质膜破裂可预防炎性小体诱导的血液凝固和炎症。
Elife. 2025 Mar 17;12:RP91329. doi: 10.7554/eLife.91329.
5
Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling.核酸感应通过偏向性凝血因子 VIIa 信号促进炎症性单核细胞迁移。
Blood. 2024 Mar 7;143(10):845-857. doi: 10.1182/blood.2023021149.
6
Inhibiting NINJ1-dependent plasma membrane rupture protects against inflammasome-induced blood coagulation and inflammation.抑制NINJ1依赖的质膜破裂可预防炎性小体诱导的血液凝固和炎症。
bioRxiv. 2024 Dec 3:2023.08.30.555561. doi: 10.1101/2023.08.30.555561.
7
Monocyte Tissue Factor Expression: Lipopolysaccharide Induction and Roles in Pathological Activation of Coagulation.单核细胞组织因子表达:脂多糖诱导及其在凝血病理激活中的作用。
Thromb Haemost. 2023 Nov;123(11):1017-1033. doi: 10.1055/a-2091-7006. Epub 2023 May 11.
8
Dysregulated haemostasis in thrombo-inflammatory disease.血栓炎症性疾病中的血液失调。
Clin Sci (Lond). 2022 Dec 22;136(24):1809-1829. doi: 10.1042/CS20220208.
9
Tissue factor in COVID-19-associated coagulopathy.COVID-19 相关凝血病中的组织因子。
Thromb Res. 2022 Dec;220:35-47. doi: 10.1016/j.thromres.2022.09.025. Epub 2022 Oct 1.
10
The Urosepsis-A Literature Review.尿路脓毒症——文献综述。
Medicina (Kaunas). 2021 Aug 25;57(9):872. doi: 10.3390/medicina57090872.